EUVIMEDEUVIMED entdecken
Crossref

Combination Therapy With Sodium Dichloroacetate and Potassium-Sodium Citrate in Patients With Stage IV Pancreatic Cancer

Ryumei H Ishiguro, Miyu Ishiguro, Atsushi Toki, Hiromasa Kurosaki, Hiroshi Terunuma, Tatsuaki Ishiguro

Cureus · 16.11.2026

DOI: 10.7759/cureus.119739 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cureus, erschienen am 16.11.2026. Verfasst von Ryumei H Ishiguro und 5 weiteren Autor:innen. Die Arbeit nennt 32 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sodium dichloroacetate (DCA), which reverses the Warburg effect of cancer cells, contributes to the alkalinization of the tumor along with a mixture of potassium-sodium (K/Na) citrate hydrate. We retrospectively evaluated the effect of the combination therapy of these in patients with stage IV pancreatic cancer. A total of 135 patients from February 2019 to August 2026 were included in this study. Eligible patients were divided into four groups: group D (DCA alone every other day), group DC (both DCA and K/Na citrate every other day), group D/C (either DCA or K/Na citrate on alternating days), and group DX (DCA every other day with ivermectin and tamoxifen every third DCA treatment). Simple pairwise comparisons of the Kaplan-Meier survival curves using the log-rank test showed significant differences between the D and DC groups and between the DC and DX groups, whereas no significant differences were observed in the other pairwise comparisons. On the other hand, the multivariable time-dependent Cox regression analysis, which accounts for the time from diagnosis to the initiation of treatment, showed a significantly higher hazard in the D, D/C, and DX groups than in the DC group. These findings suggest a potential survival benefit associated with the combination of DCA and K/Na citrate.

Zitieren

APA

Ishiguro, R. H., Ishiguro, M., Toki, A., Kurosaki, H., Terunuma, H., & Ishiguro, T. (2026). Combination Therapy With Sodium Dichloroacetate and Potassium-Sodium Citrate in Patients With Stage IV Pancreatic Cancer. Cureus. https://doi.org/10.7759/cureus.119739

Vancouver

Ishiguro RH, Ishiguro M, Toki A, Kurosaki H, Terunuma H, Ishiguro T. Combination Therapy With Sodium Dichloroacetate and Potassium-Sodium Citrate in Patients With Stage IV Pancreatic Cancer. Cureus. 2026. doi:10.7759/cureus.119739

BibTeX
@article{Ishiguro2026,
  author = {Ishiguro, Ryumei H and Ishiguro, Miyu and Toki, Atsushi and Kurosaki, Hiromasa and Terunuma, Hiroshi and Ishiguro, Tatsuaki},
  title = {Combination Therapy With Sodium Dichloroacetate and Potassium-Sodium Citrate in Patients With Stage IV Pancreatic Cancer},
  journal = {Cureus},
  year = {2026},
  doi = {10.7759/cureus.119739}
}
Kostenlos starten →